Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol LRP1 contributors: mct/pgu - updated : 14-03-2017
HGNC name low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor)
HGNC id 6692
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • thirty one copies of the ligand binding domain, equivalent to the classical LDL receptor motif, cysteine rich, arranged in four clusters
  • sixteen growth factor repeats
  • one EGF-like motif
  • a transmembrane segment (1TM)
  • a short cytoplasmic tail, with internalization signals, common 600 RD precursor of 500 and 85kD chains
  • two NPXY motifs in the intracellular domain (ICD) serve as docking sites for several cytoplasmic adaptor proteins, and interact with signaling proteins ,
  • FXNPXY63 motif not only governs cellular localization of the receptor but also exerts multiple functional effects on signalling pathways involved in cell growth regulation
  • isoforms Precursor
    HOMOLOGY
    intraspecies homolog to low-density lipoprotein receptor 1 (LDLR)
    Homologene
    FAMILY
  • LDLR superfamily
  • CATEGORY signaling , receptor
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,endosome
    intracellular,cytoplasm,organelle,lysosome
    intracellular,cytoplasm,cytosolic,vesicle
    intracellular,nucleus
    basic FUNCTION
  • macroglobulin, alpha-2-receptor (proteinase complexes receptor)
  • multiligand receptor for beta lipoprotein, binding chylomicron remnants, beta VLDL, lipoprotein lipase, lactoferrin, proteinase inhibitors
  • fibronectin catabolic receptor involved in the phagocytosis of apoptotic cells in mammals
  • involved in the processes of cell migration and invasion, as well as in the regulation of growth factor homeostasis
  • may be involved in cell migration and invasion of the retinal pigment epithelial (RPE) cells
  • may facilitate the development and growth of cancer metastases
  • playing an unique role in endocytosis of a coagulation protein trafficked to alpha-granules and not destined for lysosomal degradation
  • controls both the surface, and biosynthetic, trafficking of PRNP in neurons
  • controls signaling pathways involved in cholesterol storage and fatty acid synthesis during adipocyte differentiation
  • required for lipolysis and stimulates fatty acid synthesis independently of the noradrenergic pathway, through inhibition of GSK3B and its previously unknown target acetyl-CoA carboxylase
  • essential for the maintenance of vascular wall integrity, particularly in the presence of high plasma lipid levels
  • integrator of adipogenic differentiation and fat storage signals
  • Glucocorticoids-stimulated macrophage uptake of apoptotic cells may involve an upregulation of macrophage LRP1 expression and enhanced LRP1-mediated phagocytosis
  • endocytic receptor involved in intracellular signal transduction
  • regulates human hepatic stellate cells (HHSCs) proliferation and migration through modulation of ERK1,2 phosphorylation and TGFB extracellular levels
  • large endocytic receptor mediating the clearance of various molecules from the extracellular matrix
  • is the master regulator of extracellular levels of TIMP3, and regulates ECM catabolism
  • LRP1-dependent cell signaling that includes NTRK3 activation promotes axonal growth in the CNS
  • LRP1-dependent cell signaling mechanism involved in CNS plasticity and regeneration
  • is a large endocytic and signaling receptor that is abundant in vascular smooth muscle cells
  • likely a critical role for LRP1 in maintaining the integrity of vessels by regulating protease activity as well as matrix deposition by modulating HTRA1 and connective tissue growth factor protein levels
  • assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and myelin-associated glycoprotein
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS cell to cell transport
    PATHWAY
    metabolism
    signaling signal transduction
    a component
  • APP/APBB1/LRP1 complex is an important mediator of APP processing and affects beta-amyloid peptide production
  • INTERACTION
    DNA
    RNA
    small molecule metal binding,
  • Ca2+
  • protein
  • binding lipoproteins
  • cellular uptake and degradationof beta amyloid peptide (APP)
  • FN1
  • stimulates a canonical WNT5A signaling pathway that prevents cholesterol accumulation
  • interacting with MAFB (ICD co-localizes with MAFB to the nucleus and negatively regulates its transcriptional activity, suggesting a possible role for LRP1 in brain development)
  • in Schwann cells, LRP1 activates PI3K/Akt-mediated cell survival signaling pathways and counteracts endoplasmic reticulum stress
  • SREBF1 play a role in transcriptional regulation of LRP1
  • LRP1 and THBS2 stimulate NOTCH activity by driving trans-endocytosis of the NOTCH ectodomain into the signal-sending cell
  • in addition to its role in APP trafficking--LRP1 affects APP processing by competing for cleavage by BACE1
  • CTSD is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis
  • is an adapter to LRP1 and mediates TGFB1 signaling in signaling-competent early endosomes
  • mediates potentially the transcytosis of CTGF, which might be a crucial event that determines the distribution of CTGF in cartilage
  • LRP1-mediated internalization of CD44 appeared critical to define the adhesive properties of tumor cells
  • dictates physiological and pathological catabolism of aggrecan in cartilage as a key modulator of the extracellular activity of ADAMTS5
  • APBB1 might have signalling properties together with APP and LRP1, whereas GULP1 only mediates LRP1 transactivation
  • aggregated LDL (agLDL) prolongs the half life of LRP1 by preventing the receptor ubiquitinylation, at least in part, through CHFR targeting
  • PCSK9 is capable of inducing degradation of LRP1, the latter is not an essential factor for LDLR regulation, but the LDLR effectively competes with LRP1 for PCSK9 activity
  • HTRA1 is a novel LRP1 ligand
  • MAG binds to LRP1 with high affinity but failed to induce phosphorylation of NTRK1 or ERK1/2
  • LRP1-mediated cardiomyocyte intracellular cholesteryl ester (CE) accumulation alters the structural and physical characteristics of secreted tropoelastin (TE) through an increase in CTSS mature protein level
  • mediates clearance of blood coagulation factor VIII (F8)
  • F8 interacts likely with LRP1 via an extended surface of multiple lysine residues that starts at the bottom of the C1 domain and winds around the F8 molecule
  • PID1 serves as a cytosolic adaptor protein of the LDL receptor-related protein 1 (LRP1)
  • PID1 serves as an insulin-regulated retention adaptor protein controlling translocation of LRP1 in conjunction with SLC2A4 to the plasma membrane of adipocytes
  • by acting as an insulin-dependent retention adaptor, PID1 serves as a regulator of LRP1 function controlling the disposal of postprandial lipoproteins
  • cell & other
    REGULATION
    induced by dexamethasone induces increased macrophage expression of LRP1, which could be one mechanism behind the phagocytosis-stimulatory effect reported for glucocorticoid in terms of macrophage uptake of apoptotic cells
    Other regulated by phosphorylation
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --low  
    may be associated with abdominal aortic aneurysm progression
    Susceptibility
  • putative susceptibility factor for Alzheimer disease (see AD5), not confirmed
  • to abdominal aortic aneurysm
  • to sporadic thoracic aortic dissection (STAD)
  • Variant & Polymorphism SNP
  • rs1466535, T allele which might disrupt a binding site for SREBF1, located within intron 1 of LRP1 significantly associated to abdominal aortic aneurysm
  • SNPs in LRP1 were identified to be significantly associated with STAD
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    neurosensorial  
    target for therapeutic intervention in proliferative vitreoretinopathy
    obesity  
    pharmacological modulation of LRP1 activity might emerge as a novel rational approach for treating diabetes and obesity, as well as atherosclerosis
    diabete  
    pharmacological modulation of LRP1 activity might emerge as a novel rational approach for treating diabetes and obesity, as well as atherosclerosis
    neurologyacquired 
    LRP1 agonists promote regeneration after spinal cord injury
    ANIMAL & CELL MODELS
  • mice with conditional loss of LRP1 in post-mitotic neurons exhibit alterations in brain lipid metabolism, synapse loss, and neurodegeneration